Offer - Urjas Oil for just ₹ 1
Nosodime 1000 Injection, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Skin Infections, Pneumonia. Other than this, Nosodime 1000 Injection has some other therapeutic uses, which have been discussed ahead.
The right dosage of Nosodime 1000 Injection depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Nosodime 1000 Injection side effects, there are can be others also. These have been listed below. Normally, these side effects of Nosodime 1000 Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Nosodime 1000 Injection has a Safe effect for pregnant women and Safe effect on lactating mothers. Further, the section on Nosodime 1000 Injection related warnings talks about Nosodime 1000 Injection's effects on the liver, heart and kidney.
Nosodime 1000 Injection is contraindicated in people with pre-existing medical conditions like Kidney Disease as it can result in adverse effects. The section on Nosodime 1000 Injection contraindications lists all such conditions.
Besides this, Nosodime 1000 Injection may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Nosodime 1000 Injection is not safe while driving, and is not addiction.
Nosodime 1000 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Nosodime 1000 Injection safe for pregnant women?
Nosodime is safe for pregnant women.
Is the use of Nosodime 1000 Injection safe during breastfeeding?
Nosodime is safe for breastfeeding women.
What is the effect of Nosodime 1000 Injection on the Kidneys?
Nosodime may have mild side effects on the kidneys.
What is the effect of Nosodime 1000 Injection on the Liver?
Nosodime is not harmful for the liver.
What is the effect of Nosodime 1000 Injection on the Heart?
Using Nosodime does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Nosodime 1000 Injection unless your doctor advises you to do so -
Is this Nosodime 1000 Injection habit forming or addictive?
Forming a habit of Nosodime 1000 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nosodime 1000 Injection, you should not drive or work on any heavy machine, as Nosodime 1000 Injection can make you drowsy.
Is it safe?
Yes, Nosodime 1000 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Nosodime 1000 Injection in mental disorders is not effective.
Interaction between Food and Nosodime 1000 Injection
Taking Nosodime 1000 Injection with food is safe.
Interaction between Alcohol and Nosodime 1000 Injection
Due to lack of research, there is no information about the side effects of taking Nosodime 1000 Injection with alcohol.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; FORTAZ® (ceftazidime)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-312